0001725755-18-000001.txt : 20180104 0001725755-18-000001.hdr.sgml : 20180104 20180104123200 ACCESSION NUMBER: 0001725755-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180104 DATE AS OF CHANGE: 20180104 EFFECTIVENESS DATE: 20180104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sprout2 Inc. CENTRAL INDEX KEY: 0001725755 IRS NUMBER: 823277262 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-302368 FILM NUMBER: 18509219 BUSINESS ADDRESS: STREET 1: 4208 SIX FORKS ROAD STREET 2: SUITE 1010 CITY: RALEIGH STATE: NC ZIP: 27609 BUSINESS PHONE: 844-777-6882 MAIL ADDRESS: STREET 1: 4208 SIX FORKS ROAD STREET 2: SUITE 1010 CITY: RALEIGH STATE: NC ZIP: 27609 D 1 primary_doc.xml X0708 D LIVE 0001725755 Sprout2 Inc. 4208 SIX FORKS ROAD SUITE 1010 RALEIGH NC NORTH CAROLINA 27609 844-777-6882 DELAWARE None None Corporation true 2017 Cynthia Whitehead 154 Pine Needle Way Santa Rosa Beach FL FLORIDA 32459 Executive Officer Director Robert Whitehead 1883 Bayview Drive Tierra Verde FL FLORIDA 33715 Executive Officer Director Eric Atkins 2166 Singing Woods Drive Skaneateles NY NEW YORK 13152 Executive Officer Robert Dahl 83 Pecksland Road Greenwich CT CONNECTICUT 06831 Director Adele Oliva 331 Louella Avenue Wayne PA PENNSYLVANIA 19087 Director Pharmaceuticals Decline to Disclose 06b false 2017-12-20 false true true This offering was effected to obtain the requisite approvals by former shareholders of Sprout Pharmaceuticals, Inc., in connection with the acquisition by Sprout2 Inc. of Sprout Pharmaceuticals, Inc., and certain assets and liabilities related thereto. 0 6600000 4500000 2100000 The remaining offering amount was satisfied in cash. No additional securities will be sold in the offering. false 203 0 0 0 false Sprout2 Inc. /s/ Eric Atkins Eric Atkins Chief Financial Officer 2018-01-04